Evidence map›Paper›PMID 37556724›Full record

ArticleThe Journal of infectious diseases2023

Shigella Serotypes Associated With Carriage in Humans Establish Persistent Infection in Zebrafish.

Vincenzo Torraca, Dominik Brokatzky, Sydney L Miles, Charlotte E Chong, P Malaka De Silva, Stephen Baker, Claire Jenkins, Kathryn E Holt, Kate S Baker, Serge Mostowy

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Healthcare (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Vincenzo TorracaDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-7340-0249
Dominik BrokatzkyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-6304-3292
Sydney L MilesDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0003-2291-4105
Charlotte E ChongClinical Infection, Microbiology, and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
P Malaka De SilvaClinical Infection, Microbiology, and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Stephen BakerDepartment of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-1308-5755
Claire JenkinsGastrointestinal Bacterial Reference Unit, UK Health Security Agency, London, United Kingdom.
Kathryn E HoltDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0003-3949-2471
Kate S BakerClinical Infection, Microbiology, and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0001-5850-1949
Serge MostowyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-7286-6503
London School of Hygiene & Tropical Medicine · GBUniversity of Liverpool · GBKing's College London · GBUK Health Security Agency · GBUniversity of Cambridge · GB

Funding

Biotechnology and Biological Sciences Research Council BB/V009184/1Medical Research Council MR/R020787/1Wellcome TrustWellcome Trust 204928/Z/16/ZWellcome Trust 206444/Z/17/Z
6 · The paper itself

Abstract

Shigella represents a paraphyletic group of enteroinvasive Escherichia coli. More than 40 Shigella serotypes have been reported. However, most cases within the men who have sex with men (MSM) community are attributed to 3 serotypes: Shigella sonnei unique serotype and Shigella flexneri 2a and 3a serotypes. Using the zebrafish model, we demonstrate that Shigella can establish persistent infection in vivo. Bacteria are not cleared by the immune system and become antibiotic tolerant. Establishment of persistent infection depends on the O-antigen, a key constituent of the bacterial surface and a serotype determinant. Representative isolates associated with MSM transmission persist in zebrafish, while representative isolates of a serotype not associated with MSM transmission do not. Isolates of a Shigella serotype establishing persistent infections elicited significantly less macrophage death in vivo than isolates of a serotype unable to persist. We conclude that zebrafish are a valuable platform to illuminate factors underlying establishment of Shigella persistent infection in humans.

Indexed as

Dysentery, BacillarySexual and Gender MinoritiesShigellaAnimalsHomosexuality, MaleHumansMalePersistent InfectionSerogroupShigella flexneriZebrafishO-antigenpersistent infectionShigella flexneriShigella sonneizebrafish

Identifiers

PMID37556724
PMCPMC10582909
OpenAlexW4385716929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.